Protagonist Therapeutics Inc buy Citigroup Inc.
Start price
19.03.26
/
50%
€88.00
Target price
19.03.27
€108.80
Performance (%)
35.23%
Price
31.07.26
€119.00
Summary
This prediction is currently active. The BUY prediction by Citigroup_Inc_ for Protagonist Therapeutics Inc has seen massive gains of 35.23%. This prediction currently runs until 19.03.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Protagonist Therapeutics Inc | -0.833% | -0.833% |
| iShares Core DAX® | 2.591% | 2.467% |
| iShares Nasdaq 100 | -0.915% | -6.458% |
| iShares Nikkei 225® | 0.145% | -8.773% |
| iShares S&P 500 | -0.367% | -1.220% |
Comments by Citigroup_Inc_ for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics (PTGX) had its price target raised by Citigroup Inc. from $115.00 to $125.00. They now have a "buy" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€124.00
17.07.26
17.07.26
-
17.07.27
17.07.27
-4.03%
31.07.26
31.07.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€74.00
10.11.25
10.11.25
€84.79
10.11.26
10.11.26
60.81%
31.07.26
31.07.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€43.60
07.08.25
07.08.25
-
07.08.26
07.08.26
172.94%
31.07.26
31.07.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€46.40
17.06.25
17.06.25
€62.32
17.06.26
17.06.26
112.28%
18.06.26
18.06.26